ICICI Lombard undergoes a significant block trade on the NSE, selling 100,083 shares for approximately INR 18.5 crore, with each share priced at INR 1,848.

ICICI Lombard has announced its 26th Annual General Meeting on June 19, 2026, to be held via video conferencing. Shareholders are entitled to a dividend of ₹7 per share, with the record date set for May 29, 2026.

Health insurers demonstrated strong performance in April, yet ICICI Lombard lagged behind, signaling a mixed picture within the sector.

ICICI Lombard reported a 1.7% increase in premiums for April, reaching INR 36.54 billion, but this falls short of the industry's almost 6% growth rate.

ICICI Lombard's premium growth trails behind the industry average at a modest 1.7%, while competitors like Niva Bupar are thriving with a remarkable 30% increase, indicating a significant gap in market performance. Other players such as New India Assurance, Star Health, and Bajaj General also saw increases of 1%, 19%, and 11% respectively.

ICICI Lombard completed a significant block deal on the NSE, selling 166,882 shares at approximately Rs. 1795.5 per share, totaling around Rs. 29.96 crore.

Motilal Oswal advises investors to purchase shares of ICICI Lombard, currently trading at ₹1,886. This recommendation suggests a positive outlook for the company's performance in the near future.

ICICI Lombard reported a 7.3% increase in Q4 standalone net profit, with total sales reaching INR 5790.5 crores, marking an 11% growth. For the fiscal year, net profit surged by 10.5%, reaching INR 2771.9 crores, indicating a steady financial performance compared to the previous year.

ICHC Lombard receives a buy recommendation from HDFC Securities, setting a target price at ₹2,210. Investors may find this non-life insurance stock appealing for potential gains.

ICICI Lombard's Q4 2026 financial performance shows a 18.2% increase in GDPI year-over-year and a 7% rise for the full fiscal year. The combined ratio improved to 101.2, leading to a 10.2% jump in PBT and a 10.5% boost in profit after tax (PAT).

ICICI Lombard's Q4 earnings meet expectations and they aim to maintain a Return on Equity (RoE) between 18-20%. During a recent interview on CNBC TV18, the company shared updates about its performance.

HSBC remains optimistic about ICICI Lombard, predicting a price target of ₹2,200. This confidence is based on anticipated premium growth and an improved combined ratio in Q4FY26. For the upcoming FY27, HSBC anticipates robust revenue growth and positive EPS changes due to IFRS implementation, despite potential softness in investment income.

ICICI Lombard, an insurance company, expects a significant improvement in their combined ratio (a key performance indicator) of around 300 to 450 basis points following the implementation of new accounting procedures. This potential gain suggests a more efficient use of resources and improved financial performance.

Goldman Sachs maintains a neutral stance on ICICI Lombard, setting a target price of INR 1965. The Q4 GDPI exhibited an 18% year-on-year growth, primarily driven by a 38% surge in health and a 15% increase in motor segments.

ICICI Lombard's profit increased by 7.3% in Q4FY26, reaching INR 547 crores. Meanwhile, GMR Airports reported a slight traffic increase of 0.9%, and HDB Financial's profit after tax (PAT) soared by 41.4%, amounting to INR 751 crores.

ICICI Lombard's Q4 net profit has grown by approximately 7% year-over-year, reaching ₹5.46 billion. The company's revenue also increased substantially, climbing to ₹58 billion compared to ₹52.2 billion in the same period last year.

ICICI Lombard anticipates a positive start to FY27's Q1 and Q2, bolstered by the benefits of recent GST reductions. The company also forecasts motor insurance sector growth, signaling potential improvements in their overall performance.

ICICI Lombard has experienced growth in motor and retail health insurance due to the benefits from GST cuts and a robust distribution network. Motilal Oswal has revised its FY26/27 estimates but continues to recommend a 'Buy' rating, anticipating long-term prospects and setting a target price of Rs 2,230.

ICICI Lombard has announced a cash dividend of INR 7 per share, distributing some of its profits to shareholders.

Morgan Stanley maintains its neutral stance towards ICICI Lombard and sets a new price target of INR 1920. Investors should consider this rating as they assess their investment in the company.

ICICI Lombard's Q4 net profit grew by 7.3%, reaching ₹547 crore, with gross premiums increasing by 16.9% to ₹8,074 crore. However, the company faced an underwriting loss of ₹282.4 crore in the same period. Operating profit showed a stronger growth, up by 31.3%.

Macquarie maintains a positive outlook for ICICI Lombard, predicting shares could reach ₹2,350, due to improved profit margins, IFRS adoption, and IRDAI changes in the fiscal year 2026.

ICICI Lombard joins 7 other Nifty 200 stocks in exhibiting a positive RSI surge, suggesting potential increases in share prices and assisting traders in making informed decisions.

Today, Wipro and HDFC Life, along with other companies like HDFC Asset Management Company (HDFC AMC), CRISIL, and Angel One, will release their Q4 results. Key stocks to keep an eye on include HDBFS, ICICI Lombard, Elecon, Hathway, and Tejas Networks. These announcements might influence the market significantly.

On April 15, leading companies such as ICICI Lombard, Reliance Industrial Infra, GTPL Hathway, Tejas Networks, and Elecon Engineering will be announcing their Q4FY26 earnings results. Investors are eagerly awaiting these updates to assess the financial health of these organizations.

ICICI Lombard completed a significant share deal worth around 43.72 crore INR, trading 238,500 shares at approximately 1833.3 INR each on the NSE.

Private health insurance experienced a significant surge, growing by 19.4% in the fiscal year 2027. This growth, exceeding the industry average, was primarily driven by increased demand for health coverage and contributions from private insurers.

HSBC boosts its price targets for insurance stocks, favoring market leaders such as HDFC Life, ICICI Prudential, and SBI Life. The new targets are set at Rs 2,300 for SBI Life (up 24.9%), Rs 2,200 for ICICI Lombard (up 27.4%), and Rs 1,980 for PB Fintech (up to 35.6%).

ICICI Lombard General Insurance reported a significant 21% year-on-year increase in premiums for March, reaching INR 21.85 billion. This positive growth indicates strong performance and growing customer trust.

ICICI Lombard significantly outpaced the industry with a 21% increase in premiums compared to an average growth of 8%, while Niva Bupa showed a strong performance with a 37% boost in health premiums. However, Star Health saw more modest growth at 16%.

ICICI Lombard has announced that their Q4 FY2026 earnings call will take place on April 15, 2026 at 7:30 PM IST. Attendees can register online or dial in with provided access numbers for the call.

Jefferies warns about potential risks in ICICI Lombard, while Bank of America bumps up its recommendation for DMart to 'Buy'. Citigroup maintains a positive stance on Godrej Consumer Products. These brokerages offer sector insights and suggest investments in select stocks like ICICI Bank, Hindalco, DMart, Godrej Consumer, and IndiGo.

ICICI Lombard faces a GST demand of INR 31.2 crores spanning from 2017 to 2024, but a stay order issued by the Bombay High Court temporarily halts the financial impact.